Umeclidinium bromide (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Umeclidinium bromide" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

3,912^th place

2,496^th place

3,984^th place

2,622^nd place

1,712^th place

1,063^rd place

68^th place

117^th place

2^nd place

2^nd place

1semanticscholar.org

11^th place

8^th place

719^th place

636^th place

102^nd place

76^th place

canada.ca

"Product monograph brand safety updates". Health Canada. 7 July 2016. Retrieved 3 April 2024.

clincalc.com

"The Top 300 of 2020". ClinCalc. Retrieved 7 October 2022.
"Umeclidinium - Drug Usage Statistics". ClinCalc. Retrieved 7 October 2022.

doi.org

Feldman GJ, Edin A (December 2013). "The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects". Therapeutic Advances in Respiratory Disease. 7 (6): 311–9. doi:10.1177/1753465813499789. PMID 24004659. S2CID 5744282.

europa.eu

ema.europa.eu

"Rolufta Ellipta (previously Rolufta)". European Medicines Agency (EMA). 20 March 2017. Retrieved 28 March 2025.

handle.net

hdl.handle.net

World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

medscape.com

"FDA Approves Umeclidinium and Vilanterol Combo for COPD". Medscape. December 18, 2013.

nih.gov

dailymed.nlm.nih.gov

"Incruse Ellipta- umeclidinium aerosol, powder". DailyMed. 13 December 2023. Retrieved 28 March 2025.
"Anoro Ellipta- umeclidinium bromide and vilanterol trifenatate powder". DailyMed. 2 June 2023. Retrieved 28 March 2025.
"Trelegy Ellipta- fluticasone furoate, umeclidinium bromide and vilanterol trifenatate powder". DailyMed. 2 June 2023. Retrieved 28 March 2025.

pubmed.ncbi.nlm.nih.gov

Feldman GJ, Edin A (December 2013). "The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects". Therapeutic Advances in Respiratory Disease. 7 (6): 311–9. doi:10.1177/1753465813499789. PMID 24004659. S2CID 5744282.

semanticscholar.org

api.semanticscholar.org

Feldman GJ, Edin A (December 2013). "The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects". Therapeutic Advances in Respiratory Disease. 7 (6): 311–9. doi:10.1177/1753465813499789. PMID 24004659. S2CID 5744282.

tga.gov.au

"Prescription medicines: registration of new chemical entities in Australia, 2014". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 10 April 2023.